The FDA has granted medical manufacturer Beckman Coulter a Breakthrough Device Designation for its new plasma ratio, a blood ...
First patients with memory problems join ‘revolutionary’ trial by Oxford and Cambridge universities which could lead to ‘Holy ...
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration ...
Patients across the UK will take part in the study where their blood will be tested for a series of proteins - called ...
A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
A SIMPLE blood test that could catch dementia before major symptoms start has begun trials in NHS clinics. More than 3,000 ...
The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...
The first patients have been recruited to an “incredibly exciting” study seeking a blood test to revolutionise dementia ...
A number of blood tests have shown promise in research studies but aren’t routinely used in diagnosing dementia. | ITV ...
A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.